Recent preclinical andclinical studies have demonstrated the significant potential of GLP-1RAs in slowing the progression of neurodegenerative diseases [16, 17]
However, it can sometimes be confused with pathological conditions such as post-inflammatory hyperpigmentation, which may arise from external factors like sun exposure, trauma, or allergic reactions
In their section on limitations, the authors noted that a majority of study participants were male and a high proportion were white
[3] Teichman S, et al
In the later period, new users in both SGLT2i and GLP-1 RA cohorts were older, use of medications for type 2 diabetes was less intensive, and metabolic control was better, and although more patients had renal function assessed, patients had more severe CKD (stage 3: 44.052.1% vs
Nat Rev Gastroenterol Hepatol